TY - JOUR
T1 - Diphtheria antitoxin levels in the Netherlands
T2 - A population-based study
AU - De Melker, H. E.
AU - Berbers, G. A.M.
AU - Nagelkerke, N. J.D.
AU - Conyn-van Spaendonck, M. A.E.
PY - 1999
Y1 - 1999
N2 - In a population-based study in the Netherlands, diphtheria antitoxin antibodies were measured with a toxin-binding inhibition assay in 9,134 sera from the general population and religious communities refusing vaccination. The Dutch immunization program appears to induce long-term protection against diphtheria. However, a substantial number of adults born before the program was introduced had no protective diphtheria antibody levels. Although herd immunity seems adequate, long-term population protection cannot be assured. As more than 60% of orthodox reformed persons have antibody levels lower than 0.01 IU/ml, introduction of diphtheria into religious communities refusing vaccination may constitute a danger of spread of the bacterium.
AB - In a population-based study in the Netherlands, diphtheria antitoxin antibodies were measured with a toxin-binding inhibition assay in 9,134 sera from the general population and religious communities refusing vaccination. The Dutch immunization program appears to induce long-term protection against diphtheria. However, a substantial number of adults born before the program was introduced had no protective diphtheria antibody levels. Although herd immunity seems adequate, long-term population protection cannot be assured. As more than 60% of orthodox reformed persons have antibody levels lower than 0.01 IU/ml, introduction of diphtheria into religious communities refusing vaccination may constitute a danger of spread of the bacterium.
UR - http://www.scopus.com/inward/record.url?scp=0032717668&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032717668&partnerID=8YFLogxK
U2 - 10.3201/eid0505.990511
DO - 10.3201/eid0505.990511
M3 - Article
C2 - 10511526
AN - SCOPUS:0032717668
SN - 1080-6040
VL - 5
SP - 694
EP - 700
JO - Emerging Infectious Diseases
JF - Emerging Infectious Diseases
IS - 5
ER -